Vascular complications in essential thrombocythaemia

Małgorzata Gacka; Rajmund Adamiec

Vol 17, No 1 (2011)

Review paper

Published online: 2011-04-22

View PDF (Polish)

Download PDF file

Get Citation

Vascular complications in essential thrombocythaemia

Małgorzata Gacka, Rajmund Adamiec

Acta Angiologica 2011;17(1):37-48.

Vol 17, No 1 (2011)

Review papers

Published online: 2011-04-22

Abstract

Essential thrombocythaemia is a myeloproliferative disorder characterised by both thrombotic and haemorrhagic events. Proper diagnosis enables administration of adequate therapeutic regimens, which can prevent occurrence of further thrombotic episodes. Treatment mainly involves cytoreductive and antiplatelet drugs administered in high-risk patients. New therapeutic agents modulating JAK2 kinase activity can possibly be used in the future.
Acta Angiol 2011; 17, 1: 37–48

Abstract

Full Text:

View PDF (Polish)

Download PDF file

Get Citation

Keywords

essential thrombocythaemia; vascular complications; arterial thrombosis; venous thrombosis; JAK2 V617F mutation

About this article

Title

Vascular complications in essential thrombocythaemia

Journal

Acta Angiologica

Issue

Vol 17, No 1 (2011)

Article type

Review paper

Pages

37-48

Published online

2011-04-22

Page views

976

Article views/downloads

1928

Bibliographic record

Acta Angiologica 2011;17(1):37-48.

Keywords

essential thrombocythaemia
vascular complications
arterial thrombosis
venous thrombosis
JAK2 V617F mutation

Authors

Małgorzata Gacka
Rajmund Adamiec